Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study - Wikidata - wikimedia - TriplyDB

Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study

Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study

http://www.wikidata.org/entity/Q57260389

about

Cardiovascular risk Stroke genetics: prospects for personalized medicine Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression Late-onset epilepsy and occult cerebrovascular disease Histone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model.Profibrinolytic effect of the epigenetic modifier valproic acid in man.Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study.Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study Plaques on the wall: inducing anticonvulsant use and atherogenesis.Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings Enzyme induction with antiepileptic drugs: cause for concern?Genetic profiles in ischaemic stroke.Mechanisms and treatment of ischaemic stroke--insights from genetic associations.Epilepsy, excess deaths and years of life lost from external causes.Epilepsy as a systemic condition: Link with somatic comorbidities.The association between dementia and epilepsy: A systematic review and meta-analysis.Postoperative adverse outcomes in surgical patients with epilepsy: a population-based study.Health-related behaviors and comorbidities in people with epilepsy: Changes in the past decade.Illuminating drug action by network integration of disease genes: a case study of myocardial infarction.A reduced risk of stroke with lithium exposure in bipolar disorder: a population-based retrospective cohort study.Trimetazidine potentiates the antiepileptic activity and ameliorates the metabolic changes associated with pentylenetetrazole kindling in rats treated with valproic acid.Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.White Matter Hyperintensities on Brain Magnetic Resonance Imaging in People with Epilepsy: A Hospital-Based Study.Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.Dosage of angiotensin-II receptor blockers in heart failure patients following changes in Danish drug reimbursement policies.Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study Dual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells

P2860

Q26825634-AF3C26EF-253F-459F-B323-DE797355F602 Q27006885-E4A43825-0491-4FE3-8959-1468AFBE1C65 Q28387103-953351A6-7120-4A28-96E0-D29870D6736E Q28480965-AFD8D84D-A854-4BF0-A800-C3C1B6D981FC Q30755317-304AC46C-11EF-464B-B0A7-FEA666CB8C3B Q33599573-A16C3D37-9AE8-47FD-A47E-8C32B09D8CDA Q34306821-52BE48A5-847B-4CE6-B404-934C97D3869A Q34532001-26C4F474-1D84-4A49-81AE-1B0DADE2DA5A Q35517710-AF5EDA4C-6FB2-42C4-A09E-70BD6AEB6C9B Q35856372-ED870D64-1050-4C2A-9FF1-965BE4F8D9C6 Q35960111-242245BC-CD7A-46C6-9839-3724C9C6DB39 Q36623450-378F45CA-288B-4ACA-8D84-BAAEB857F687 Q37310447-C5BC0149-DA14-4B92-8C9A-AA8E152CDC55 Q38046892-FE11B307-9E77-4075-83B6-ECD0D2DAFE50 Q38115496-585CDBA0-75CA-4DAF-AC9E-8A5FCE622FAC Q38263023-A86805C0-0D4C-4DAF-92A8-432A4123AF9B Q38621227-74F14DF9-28AE-4D42-BC50-F6A76B627F8D Q38749358-581F8E4B-B2B2-4100-8DF5-0CB36BFF44DF Q38842852-DA003C40-E1FB-4EE1-8EEB-0762D6DD1580 Q40030836-4E74DCF5-1FF8-4E20-8C95-9CE1D3346F16 Q40274156-E9577A2A-62C7-4E79-8B54-AD77CAE2B20C Q40672660-6B2BF2E7-D382-4262-B75F-B3DE255BB974 Q41334184-43DCCE12-FCDB-4379-8ABD-107CACFC46F7 Q46986264-C576BCB6-BCD4-429E-81A5-892D4D13581D Q47299769-BD193782-7373-4B91-ACB7-3293ACCAFF4A Q48007999-A64A2F5B-B8F9-4E0B-B7F2-7F805B7EB2AC Q48487114-1F99AA6D-5CDE-45C7-9976-247AE83DF4F8 Q50561874-D8C0C9C4-3BAF-411A-81A2-F2E3005D6861 Q57260384-589CD40F-3763-4915-A238-36EDE13D870B Q58565218-C776D916-561F-40B1-AC70-F149BA854744

P2860

Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study

http://www.wikidata.org/entity/Q57260389

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2010

@uk

name

Valproate attenuates the risk ...... psy: a nationwide cohort study

@en

Valproate attenuates the risk ...... psy: a nationwide cohort study

@nl

type

label

Valproate attenuates the risk ...... psy: a nationwide cohort study

@en

Valproate attenuates the risk ...... psy: a nationwide cohort study

@nl

prefLabel

Valproate attenuates the risk ...... psy: a nationwide cohort study

@en

Valproate attenuates the risk ...... psy: a nationwide cohort study

@nl

P1433

Q57260389-B1901EB5-8FCE-4CE5-9635-E4893CEC2F49

P1476

Q57260389-3D6DF371-A2D2-400A-9A17-640B263C0306

P2093

Q57260389-2D8F194B-29EA-46C2-B491-9BE748A94881

Q57260389-42DDE9CB-ADC9-4F04-93E3-DD6DFF9319DE

Q57260389-4BD63EDC-A316-4C0F-BA13-C8AD603F6EAC

Q57260389-53D5B40D-BA50-4464-B72F-21812169BF01

P2860

Q57260389-02C05DFB-DF27-4737-A275-DD535308E047

Q57260389-0C348B41-769F-4385-B708-AC8C87C5E982

Q57260389-0C5AC35F-2235-4DB5-868E-A3EF1F8C9F42

Q57260389-10404AB2-0072-486C-B857-C13F219EA7C7

Q57260389-117D44CA-BBD4-44E3-915D-146E461DABF1

Q57260389-13D6B33C-D414-4D73-80D6-8CDCC5170F06

Q57260389-147BB59E-DF11-433A-A8BA-2A90555E41F3

Q57260389-20553005-1B15-4AD6-8B7E-DE8876EBAF14

Q57260389-210E363C-72A6-488B-9B38-113C877544F8

Q57260389-277E33F4-6E85-4434-9963-BAF5CC9AF699

P304

Q57260389-830BEE36-B0FE-4A7E-9D50-2E27E212AC85

P31

Q57260389-5236199C-9606-4FED-844E-1D1273860545

P356

Q57260389-C0409DBE-4233-49BE-9274-E87964FE99F0

P433

Q57260389-8DAE30B2-CB12-4953-80A9-9742679AEA68

P478

Q57260389-660B2E33-F536-40A0-A069-5C7B9C3C9E22

P50

Q57260389-4025FACE-326E-4A1A-8C20-DA0D57C7C4F1

Q57260389-6417990F-28C3-4CFD-BB7A-5D8E348B53FE

Q57260389-66F7A52F-7310-44A9-82C1-472780CAEA6D

Q57260389-7FF46A45-BC46-4E5A-B4FE-BDA87EFC7F59

Q57260389-9212C11D-2026-4683-AD58-234216E6F489

P577

Q57260389-CADA84C4-6037-4267-8D99-2DDF2663D0DC

P698

Q57260389-7A8A4CA6-D6E0-48A2-B799-1980AC0F51B5

P921

Q57260389-0691E74E-C23F-40F7-9B3C-50768746F663

Q57260389-70EDC610-B021-456C-8469-0AC4DD69F987

P356

P1433

Pharmacoepidemiology and Drug Safety

P1476

Valproate attenuates the risk ...... psy: a nationwide cohort study

@en

P2093

Charlotte Andersson

http://www.w3.org/2001/XMLSchema#string

Michelle Schmiegelow

http://www.w3.org/2001/XMLSchema#string

Peter Weeke

http://www.w3.org/2001/XMLSchema#string

Steen Zabell Abildstrøm

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis.

The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry.

Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery.

Valproate-associated coagulopathies are frequent and variable in children.

High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

Inhibit GSK-3beta or there's heartbreak dead ahead.

Nuclear factor kappa-B and the heart.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

P304

146-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.2073

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Christian Torp-Pedersen

Gunnar Hilmar Gislason

Peter Riis Hansen

Jonas Bjerring Olesen

P577

2010-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21254285

http://www.w3.org/2001/XMLSchema#string

P921